Pharmaroth Labs Earnings Estimate
Pharmaroth Labs Earnings per Share Projection vs Actual
About Pharmaroth Labs Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Pharmaroth Labs earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Pharmaroth Labs estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Pharmaroth Labs fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -2.6 M | -2.5 M | |
| Earnings Yield | (0.09) | (0.10) | |
| Price Earnings Ratio | (11.21) | (11.77) | |
| Price Earnings To Growth Ratio | 0.21 | 0.20 |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharmaroth Labs. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For more detail on how to invest in Pharmaroth Stock please use our How to Invest in Pharmaroth Labs guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pharmaroth Labs. If investors know Pharmaroth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pharmaroth Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pharmaroth Labs is measured differently than its book value, which is the value of Pharmaroth that is recorded on the company's balance sheet. Investors also form their own opinion of Pharmaroth Labs' value that differs from its market value or its book value, called intrinsic value, which is Pharmaroth Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pharmaroth Labs' market value can be influenced by many factors that don't directly affect Pharmaroth Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pharmaroth Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pharmaroth Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pharmaroth Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.